Dr. Vertès brings to his role extensive experience in the pharmaceutical and industrial biotechnology sectors, in Europe, North America and Asia.

 

• Dr. Vertès is currently with NxR Biotechnologies (a boutique global consulting firm based in Basel, Switzerland) as Managing Director, advising clients on strategy, business development, in/out-licensing, entrepreneurship and investment, with a focus on cell- and gene-based therapies, oncology, inflammation, neurodegenerative diseases, and rare diseases.

• He is active in alliance management and external innovation for Mesoblast.

• Dr. Vertès previously held positions of increasing responsibility in pharmaceuticals at Lilly and Pfizer.

• At Roche, he notably led through an external innovation partnering function the global cell therapeutics strategy and implementation team from 2007-2010.

• In addition, he has worked in petrochemicals and sustainable chemistry at Mitsubishi Chemical Corporation, public research at the Institut Pasteur and RITE/Kyoto.

• Dr. Vertès has also conducted contract research at Battelle Memorial Institute and PPD/BioDuro, as well as consulting for the Australian Strategic Policy Institute

• With a focus on innovation commercialization, he has been a key player in the evaluation, selection, deal making, implementation and alliance management of numerous novel products and emerging technologies.

• Dr Vertès is a lead editor of several science and strategy books in the fields of regenerative medicine and sustainable chemistry.